Baxter Sally L, Bass Jeremy S, Sitapati Amy M
Health Department of Biomedical Informatics, University of California San Diego, La Jolla, California, United States.
Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, California, United States.
ACI open. 2020 Jul;4(2):e108-e113. doi: 10.1055/s-0040-1716748.
Electronic health record (EHR) vendors now offer "off-the-shelf" artificial intelligence (AI) models to client organizations. Our health system faced difficulties in promoting end-user utilization of a new AI model for predicting readmissions embedded in the EHR.
The aim is to conduct a case study centered on identifying barriers to uptake/utilization.
A qualitative study was conducted using interviews with stakeholders. The interviews were used to identify relevant stakeholders, understand current workflows, identify implementation barriers, and formulate future strategies.
We discovered substantial variation in existing workflows around readmissions. Some stakeholders did not perform any formal readmissions risk assessment. Others accustomed to using existing risk scores such as LACE+ had concerns about transitioning to a new model. Some stakeholders had existing workflows in place that could accommodate the new model, but they were not previously aware that the new model was in production. Concerns expressed by end-users included: whether the model's predictors were relevant to their work, need for adoption of additional workflow processes, need for training and change management, and potential for unintended consequences (e.g., increased health care resource utilization due to potentially over-referring discharged patients to home health services).
AI models for risk stratification, even if "off-the-shelf" by design, are unlikely to be "plug-and-play" in health care settings. Seeking out key stakeholders and defining clear use cases early in the implementation process can better facilitate utilization of these models.
电子健康记录(EHR)供应商现在向客户机构提供“现成的”人工智能(AI)模型。我们的医疗系统在推动最终用户使用嵌入电子健康记录中的用于预测再入院的新AI模型时遇到了困难。
旨在进行一项以识别采用/使用障碍为中心的案例研究。
通过与利益相关者进行访谈开展了一项定性研究。这些访谈用于识别相关利益者、了解当前工作流程、识别实施障碍并制定未来策略。
我们发现围绕再入院的现有工作流程存在很大差异。一些利益相关者没有进行任何正式的再入院风险评估。其他习惯使用现有风险评分(如LACE+)的人对过渡到新模型存在担忧。一些利益相关者已有可适应新模型的工作流程,但他们之前并不知道新模型已投入使用。最终用户表达的担忧包括:模型的预测因素是否与他们的工作相关、是否需要采用额外的工作流程、是否需要培训和变革管理,以及是否存在意外后果的可能性(例如,由于可能将出院患者过度转诊至家庭健康服务而导致医疗资源利用增加)。
用于风险分层的AI模型,即使在设计上是“现成的”,在医疗环境中也不太可能“即插即用”。在实施过程早期找出关键利益相关者并定义明确的用例可以更好地促进这些模型的使用。